Cargando…
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial
AIMS: To characterize the relationship between blood pressure (BP) or heart rate and mortality and morbidity in chronic obstructive pulmonary disease (COPD). METHODS AND RESULTS: We performedpost hoc analysis of baseline BP or heart rate and all-cause mortality and cardiovascular events in the SUMMI...
Autores principales: | Byrd, James Brian, Newby, David E, Anderson, Julie A, Calverley, Peter M A, Celli, Bartolome R, Cowans, Nicholas J, Crim, Courtney, Martinez, Fernando J, Vestbo, Jørgen, Yates, Julie, Brook, Robert D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263699/ https://www.ncbi.nlm.nih.gov/pubmed/30101300 http://dx.doi.org/10.1093/eurheartj/ehy451 |
Ejemplares similares
-
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
por: Vestbo, Jørgen, et al.
Publicado: (2019) -
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019) -
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial
por: Brigham, Emily P., et al.
Publicado: (2021) -
Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease
por: Adamson, Philip D., et al.
Publicado: (2018) -
FEV(1) is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
por: Bikov, Andras, et al.
Publicado: (2020)